Considering the complexity of the roles that VSMCs played in the development of atherosclerosis and the importance of VSMCs in atherosclerotic plaques, we assume that activation of the AMPK–Pdlim5 pathway by metformin may be beneficial for suppressing diabetes-accelerated atherosclerosis via the inhibition of VSMC migration. This evidence concerns the gene PRKAA2 and diabetes mellitus.